Skip to main content

Table 4 Univariate log-rank and multivariate analyses for local recurrence-free and metastasis-free survivals in primary localized IHCC

From: Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma

Parameter

Category

Case No

Local recurrence-free survival

Metastasis-free survival

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

No. of event

p-value

R.R

95% C.I

p-value

No. of event

p-value

R.R

95% C.I

p-value

Gender

Male

108

54

0.2170

–

–

–

21

0.1008

–

–

–

Female

74

31

 

–

–

–

44

 

–

–

–

Age (years)

 < 65

107

55

0.2993

–

–

–

42

0.2936

–

–

–

 ≥ 65

75

30

 

–

–

–

23

 

–

–

–

Hepatitis

Hepatitis B

72

33

0.7333

–

–

–

26

0.8762

–

–

–

Hepatitis C

29

13

 

–

–

–

11

 

–

–

–

Non-B, non-C

81

39

 

–

–

–

28

 

–

–

–

Intrahepatic lithiasis

Not identified

102

41

0.0551

–

–

–

31

0.1000

–

–

–

Present

80

44

 

–

–

–

34

 

–

–

–

Surgical margin

R0

163

71

 < 0.0001*

1

–

 < 0.001*

54

 < 0.0001*

1

 

0.014*

R1

19

14

 

3.428

1.764–6.663

 

11

 

2.467

1.202–5.062

 

Primary tumor (T)

T1

87

28

 < 0.0001*

1

-

0.015*

21

 < 0.0001*

1

-

0.006*

T2

61

32

 

1.715

0.985–2.985

 

26

 

2.180

1.220–3.895

 

T3

34

25

 

2.459

1.327–4.559

 

18

 

2.757

1.394–5.454

 

Histological variants

Large duct type

105

58

0.0085*

1

–

0.591

43

0.0759

–

–

–

Small duct type

77

27

 

0.870

0.523–1.446

 

22

 

–

–

–

Histological Grade(Differentiation)

Well

61

28

0.0299*

1

–

0.627

22

0.1794

–

–

–

Moderately

66

27

 

0.960

0.551–1.671

 

22

 

–

–

–

Poorly

55

30

 

1.238

0.719–2.132

 

21

 

–

–

–

UBE2C Exp

Low expression

91

29

 < 0.0001*

1

–

0.004*

24

0.0008*

1

–

0.022*

High expression

91

56

 

2.087

1.268–3.438

 

41

 

1.846

1.092–3.121

 
  1. *Statistically significant